CLONOMAB • Research, general,PARIS
Executives - CLONOMAB Buy the executives list from same sector
Location - CLONOMAB
Key figures - CLONOMAB
Activities - CLONOMAB
Other classifications (for some countries)
NAF Rev.2 (FR 2008) : Research and experimental development on biotechnology (7211Z)
NACE Rev.2 (EU 2008) : Research and experimental development on biotechnology (7211)
ISIC 4 (WORLD) : Research and experimental development on natural sciences and engineering (7210)
NACE Rev.2.1 (EU 2025) : Research and experimental development on natural sciences and engineering (7210)
Kompass membership
| Kompass ID? | FRA00DRIX |
|---|
Legal information - CLONOMAB
| Type | Headquarters |
|---|---|
| Year established | Information available as an option|
| Legal form | Société à responsabilité limitée (sans autre indication) |
| Activity (NAF08) | Research and experimental development on biotechnology (7211Z) |
| Corporate capital | 4,000 EUR |
| SIREN | Information available as an option |
| SIRET (Siège) | Information available as an option |
| VAT no |
Information available as an option
|
| No employees (address) | Information available as an option |
| No employees | Information available as an option |
Other Companies recommended by Kompass:
You might also like:
Need help finding the right information ? Let us guide you to the best solutions !
I am looking for :
The shortest path to your future customers and suppliers
"I would recommend EasyBusiness to all sales teams."
Test EasyBusiness for 14 days for free
No payment or credit card required
All-in-one prospecting solution designed to improve your productivity
Find your next customer today! Your shortcut to faster, more targeted and successful lead generation
Register for free and turn reliable data into real business opportunities
Your data is used to recontact you or send you communications and may be processed by Kompass, for the purposes of legitimate interest (Article 6 1.f of the GDPR).
You may object to its processing by email: dpo@kompass.com.
Find out more: see our privacy policy.